Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis
Clinical Implication of Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis
Sponsor: Rigshospitalet, Denmark
Terminated
The study was stopped due to health-related issues in the research group, that hindered inrolement of patients.
This NA trial investigates Intermetatarsal Bursitis and Rheumatoid Arthritis and is currently terminated or withdrawn. Rigshospitalet, Denmark leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting NA
-
Dec 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Apr 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rigshospitalet, Denmark
- The Danish Rheumatism Association
For direct contact, visit the study record on ClinicalTrials.gov .